Platinum-xanthene-bromine complex

The platinum-futon-bromoyl complex in the prior art was solved by using new platinum-futon-bromoyl complexes, including Pt, ligands in accordance with formula (I) and bromine ligands, was used to resolve the hydroformylation reaction of the platinum-futon-bromoyl complexes in the prior art, including Pt, ligands in accordance with formula (I), and bromine ligands, was found to be resolved in the prior art. The problem of low catalytic efficiency in the problem has achieved a significant improvement in yield.

CN116265477BActive Publication Date: 2025-02-18EVONIK OXENO GMBH & CO KG
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202211612193.7
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2021-12-17
Filing Date
2022-12-15
Publication Date
2025-02-18
Estimated Expiration
2042-12-15

AI Technical Summary

Technical Problem

The existing Pt(4,5-bis(diphenylphosphine)-9,9-dimethyloxanthracene)Cl2 complex has low catalytic efficiency in hydroformylation reaction, making it difficult to improve yield .

Method used

New platinum-furoton-bromolylation complexes, including Pt, ligands according to formula (I), and bromine ligands are used for catalyzing the hydroformylation reaction. The structure of the complex includes Pt(4,5-bis(diphenylphosphine)-9,9-dimethyloxanthracene)Br2, which improves the efficiency of the catalytic reaction by adjusting the composition of ligand and bromine ligands. .

Benefits of technology

The yield of the hydroformylation reaction was significantly improved. For example, in the hydroformylation reaction of 1-octene, the yield of PtBr2 reached 99%, while the yield of PtCl2 was only 30%.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure FDA0005087057780000011
    Figure FDA0005087057780000011
  • Figure FDA0005087057780000012
    Figure FDA0005087057780000012
  • Figure GDA0005087057800000011
    Figure GDA0005087057800000011
Patent Text Reader

Abstract

The invention relates to a platinum-xanthene-bromide complex and use thereof in catalyzing a hydroformylation reaction.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to a platinum-xanthene-bromine complex and its use in catalyzing hydroformylation reaction. Background Art

[0002] C. Botteghi et al., Journal of Molecular Catalysis A: Chemical 200, (2003), 147-156 describe the use of Pt(4,5-bis(diphenylphosphino)-9,9-dimethylxanthene)Cl2 for the hydroformylation of 2-tosyloxystyrene. Summary of the invention

[0003] The problem to be solved by the present invention is to provide a novel complex which, compared with the Pt(4,5-bis(diphenylphosphino)-9,9-dimethylxanthene)Cl2 complexes described in the prior art, should provide an increased yield in the catalysis of hydroformylation reactions.

[0004] This object is achieved by the complexes described in the present invention.

[0005] The complexes include:

[0006] a) Pt;

[0007] b) a ligand conforming to formula (I):

[0008]

[0009] Where R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 Selected from: -H, -(C1-C 12 )-alkyl, -(C6-C 20 )-aryl;

[0010] And, if R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 Yes-(C6-C 20 )-aryl, the aromatic ring may have a member selected from -(C1-C 12 )-alkyl, -O-(C1-C 12 )-alkyl substituents;

[0011] c) Bromine ligand.

[0012] Terminology (C1-C 12 )-Alkyl includes straight-chain and branched alkyl groups having 1 to 12 carbon atoms. These are preferably (C1-C8)-alkyl, more preferably (C1-C6)-alkyl, most preferably (C1-C4)-alkyl.

[0013] Suitable (C1-C 12 )-alkyl, in particular methyl, ethyl, propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, 2-pentyl, 2-methylbutyl, 3-methylbutyl, 1,2-dimethylpropyl, 1,1-dimethylpropyl, 2,2-dimethylpropyl, 1-ethylpropyl, n-hexyl, 2-hexyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1,1-dimethylbutyl, 1,2- Dimethylbutyl, 2,2-dimethylbutyl, 1,3-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1,1,2-trimethylpropyl, 1,2,2-trimethylpropyl, 1-ethylbutyl, 1-ethyl-2-methylpropyl, n-heptyl, 2-heptyl, 3-heptyl, 2-ethylpentyl, 1-propylbutyl, n-octyl, 2-ethylhexyl, 2-propylheptyl, nonyl, decyl.

[0014] Terminology (C6-C 20 )-Aryl includes monocyclic or polycyclic aromatic hydrocarbon groups having 6 to 20 carbon atoms. These are preferably (C6-C 14 )-aryl, more preferably (C6-C 10 )-aryl.

[0015] Suitable (C6-C 20 )-aryl, in particular phenyl, naphthyl, indenyl, fluorenyl, anthracenyl, phenanthrenyl, naphthacene, Preferred (C6-C 20 )-Aryl is phenyl, naphthyl and anthracenyl.

[0016] In one embodiment, R 2 , R 3 , R 5 , R 6 , R 7 , R 8 Selected from: -(C1-C 12 )-alkyl, -(C6-C 20 )-aryl.

[0017] In one embodiment, R 5 , R 6 , R 7 , R 8Yes-(C6-C 20 )-aryl.

[0018] In one embodiment, R 5 , R 6 , R 7 , R 8 Yes - Ph.

[0019] In one embodiment, R 2 and R 3 Yes - (C1-C 12 )-alkyl.

[0020] In one embodiment, R 2 and R 3 It is -CH3.

[0021] In one embodiment, R 1 and R 4 Yes -H.

[0022] In one embodiment, the ligand according to formula (I) has structure (1):

[0023]

[0024] (1): 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene.

[0025] In one embodiment, the complex has exactly one ligand corresponding to formula (I).

[0026] In one embodiment, the complex has at least two bromine ligands.

[0027] In one embodiment, the complex has exactly two bromine ligands.

[0028] In one embodiment, the complex has the following structure: Pt(4,5-bis(diphenylphosphino)-9,9-dimethylxanthene)Br2.

[0029] In addition to the complexes themselves, their use for catalyzing hydroformylation reactions is also claimed.

[0030] The complex is used for catalyzing hydroformylation reaction. DETAILED DESCRIPTION

[0031] The present invention will be described in detail below by means of working examples.

[0032] Experimental Description

[0033] PtX2 (X = halogen), ligand and oven-dried stirring rod are loaded into a vial. The vial is then sealed with a diaphragm (PTFE-coated styrene-butadiene rubber) and a phenolic resin cap. The vial is evacuated and refilled with argon three times. Toluene and olefins are added to the vial using a syringe. The vial is placed in an alloy plate (Legierungsplatte) and transferred to a 4560 series autoclave from Parr Instruments under an argon atmosphere. After purging the autoclave three times with CO / H2, the synthesis gas pressure is increased to 40 bar at room temperature. The reaction is carried out at 120°C for 20h / 18h. After the reaction is completed, the autoclave is cooled to room temperature and carefully decompressed. The yield and selectivity are determined by GC analysis.

[0034] Hydroformylation of 1-octene

[0035]

[0036] Reaction conditions:

[0037] 20 mmol of 1-octene, 1.0 mol% of Pt, 2.2 equivalents of 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene (1), solvent: toluene, p(CO / H2): 40 bar, T: 120°C, t: 20 h.

[0038] Yield:

[0039] PtBr2: 99%

[0040] PtCl2: 30%.

[0041] Halogen Variations (2-Octene)

[0042]

[0043] Reaction conditions:

[0044] 20 mmol of 2-octene, 1.0 mol% of Pt, 1.1 equivalents of 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene (1), solvent: toluene, p(CO / H2): 40 bar, T: 120°C, t: 20 h.

[0045] Yield:

[0046] PtBr2: 99%

[0047] PtCl2: 16%.

[0048] Halogen Variations (1-Octene)

[0049] Reaction conditions:

[0050] 10.0 mmol of 1-octene, 0.1 mol% PtX2, 2.2 equivalents of ligand, solvent: toluene, p(CO / H2): 40 bar, T: 120°C, t: 20 h.

[0051] Yield:

[0052]

[0053] Changes in ligands and changes in halogens

[0054] Reaction conditions:

[0055] 1.0 mmol of 2-octene, 0.5 mol% PtX2, 2.0 equivalents of ligand, solvent: toluene, p(CO / H2): 40 bar, T: 120°C, t: 18 h.

[0056] Yield:

[0057]

[0058] Changes in equivalence and halogen content

[0059] Reaction conditions:

[0060] 1.0 mmol of 1-octene, 1.0 mol% Pt(acac)2, LiX (X = halogen), 2.2 equivalents of 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene (1), solvent: toluene, p(CO / H2): 40 bar, T: 120°C, t: 20 h.

[0061] LiX equivalent X Yield [%] 0.5 Br 68 2.0 Br 71 1.5 Cl 0 4.0 Cl 0。

[0062] As shown by the experimental results, this object is achieved by the complex according to the invention.

Claims

1. A complex comprising: a) Pt; b) a ligand conforming to formula (I): Where R 1 and R 4 Yes - H, R 2 and R 3 Yes - (C1-C 12 )-alkyl, and R 5 , R 6 , R 7 , R 8 Yes-(C6-C 20 )-aryl; c) Bromine ligand.

2. The complex according to claim 1, The ligand conforming to formula (I) has structure (1):

3. The complex according to any one of claims 1 to 2, Therein the complex has exactly one ligand which corresponds to formula (I).

4. The complex according to any one of claims 1 to 2, The complex has at least two bromine ligands.

5. The complex according to any one of claims 1 to 2, Therein the complex has exactly two bromine ligands.

6. The complex according to any one of claims 1 to 2, The complex has the following structure: Pt(4,5-bis(diphenylphosphino)-9,9-dimethylxanthene)Br2.

7. Use of the complex according to any one of claims 1 to 6 for catalyzing hydroformylation reactions.

Citation Information

Patent Citations

  • Vinyl ester production from acetylene and carboxylic utilizing homogeneous catalyst

    CN102414162A

  • Catalyst for preparing linear-chain aldehyde in high-selectivity manner as well as preparation and application thereof

    CN109806911A